Natives | Migrants | ||||
---|---|---|---|---|---|
N | % | n | % | p-value | |
Diabetes type II | 134 | 100 | 81 | 96.4 | 0.056 |
Diabetes-related diseases | 65 | 48.5 | 26 | 31.0 | 0.011 |
Polyneuropathy | 58 | 43.3 | 25 | 29.8 | 0.045 |
Carotid artery disease | 28 | 20.9 | 18 | 21.4 | 0.925 |
Nephropathy | 19 | 14.2 | 10 | 11.9 | 0.630 |
Retinopathy | 10 | 7.5 | 4 | 4.8 | 0.574 |
Diabetic feet syndrome | 9 | 6.7 | 2 | 2.4 | 0.210 |
Renal insufficiency | 6 | 4.5 | 9 | 10.7 | 0.077 |
Coronary disease | 37 | 27.6 | 12 | 14.3 | 0.022 |
Past myocardial infarction | 20 | 14.9 | 10 | 11.9 | 0.529 |
Coronary artery bypass | 8 | 6.0 | 3 | 3.6 | 0.536 |
Peripheral vascular disease | 13 | 9.7 | 7 | 8.3 | 0.733 |
Other stroke risk factors | |||||
Hypertension | 124 | 92.5 | 63 | 75.0 | <0.001 |
Atrial fibrillation | 10 | 7.5 | 2 | 2.4 | 0.135 |
Hyperlipidemia | 71 | 53.0 | 36 | 42.9 | 0.145 |
Current smoker | 24 | 17.9 | 23 | 27.4 | 0.098 |
Former smoker | 6 | 4.5 | 16 | 19.0 | 0.001 |
Obesity with BMI ≥30 | 73 | 54.5 | 53 | 63.1 | 0.210 |
Regular alcohol intake | 4 | 3.0 | 0 | 0.0 | 0.301 |
Prior stroke | 18 | 13.4 | 9 | 10.7 | 0.553 |
Oral contraceptive | 1 | 0.7 | 6 | 7.1 | 0.014 |
Family history of stroke | 17 | 12.7 | 22 | 26.2 | 0.011 |
Diabetes therapy | |||||
Participant in disease management program | 134 | 100 | 84 | 100 | |
Dietary therapy only | 47 | 35.1 | 26 | 31.0 | 0.530 |
Metformin | 72 | 53.7 | 50 | 59.5 | 0.402 |
Insulin therapy | 31 | 23.1 | 19 | 22.6 | 0.930 |
Years in practice, average (span), yrs | 13.5 (1–36) | 19.0 (1–40) | <0.001 | ||
Practice contacts in last year, average (span), n | 10.4 (1–21) | 9.4 (1–23) | 0.109 | ||
HbA1c, average (SD),% | 6.9 (5.0-13.7) | 7.3 (5.4-12.4) | 0.319 | ||
LDL, average (SD), mg/dl | 128 (37–260) | 122 (32–233) | 0.098 | ||
Blood pressure, average, mmHg | 140/79 | 136/80 | 0.409 |